BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2014-05-14
What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2014-05-14 (fiscal Q1 2014): 31 published measures, 80 facts as tagged in accession 0001144204-14-030532.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-14
- Fiscal period
- fiscal Q1 2014
- Accession
- 0001144204-14-030532 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,252,924 | USD | |
| At 2013-12-31 | 1,382,915 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 8,236,016 | USD | |
| At 2013-12-31 | 8,067,984 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -6,983,092 | USD | |
| At 2013-12-31 | -6,685,069 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -1,669,676 | USD | 90 |
| 2008-12-30 to 2014-03-31 | -21,492,454 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | -1,565,998 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -806,728 | USD | 90 |
| 2008-12-30 to 2014-03-31 | -10,406,409 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | -771,773 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 176,936 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 375 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 17,644 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 1,130 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 715,010 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 11,664,401 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 1,270,000 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 980 | USD | 90 |
| 2008-12-30 to 2014-03-31 | -1,147,632 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 25,515 | USD | |
| At 2013-12-31 | 35,568 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 373,499 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 5,316,543 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 255,530 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -1,428,418 | USD | 90 |
| 2008-12-30 to 2014-03-31 | -18,538,313 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | -1,299,581 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 137,317 | USD | |
| At 2013-12-31 | 239,802 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 73,131 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 1,324,723 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 197,868 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 7,926,643 | USD | |
| At 2013-12-31 | 7,502,550 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,203,090 | USD | |
| At 2013-12-31 | 1,269,970 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 0 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 32,000 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 1,428,733 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 18,554,382 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 1,300,549 | USD | 90 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 17,904 | USD | |
| At 2013-12-31 | 17,965 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 315 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 16,069 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 968 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 493,741 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 3,057,692 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 400,442 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 21,833,014 | shares | |
| At 2013-12-31 | 19,074,552 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 14,508,606 | USD | |
| At 2013-12-31 | 13,139,712 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,090,092 | USD | |
| At 2013-12-31 | 1,107,545 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,286,825 | USD | |
| At 2013-12-31 | 1,176,662 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 9,053 | USD | |
| At 2013-12-31 | 20,739 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 636,000 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 9,910,011 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 640,110 | USD | 90 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 25,517 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 365,914 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 26,735 | USD | 90 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -241,258 | USD | 90 |
| 2008-12-30 to 2014-03-31 | -2,954,141 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | -266,417 | USD | 90 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -61 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 17,904 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 1,338 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -59,380 | USD | 90 |
| 2008-12-30 to 2014-03-31 | 1,157,079 | USD | 1918 |
| 2013-01-01 to 2013-03-31 | 1,840 | USD | 90 |
Inspect the source
- Entity
- BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
- Captured
- 2026-09-19T11:18:28.483Z
- SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))